Timothy Mitchell
Founder chez SAREUM HOLDINGS PLC
Fortune : 140 222 $ au 31/03/2024
Profil
Timothy John Mitchell was the founder of Sareum Holdings Plc, where he held the title of Chief Executive Officer & Executive Director until his departure.
Sareum Holdings Plc was founded in 2003.
Dr. Mitchell's former positions include Director-Computational Chemistry at Cambridge Discovery Chemistry and Director-Structure Based Discovery at Millennium Pharmaceuticals Research & Development Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAREUM HOLDINGS PLC
1,44% | 28/03/2024 | 1 032 561 ( 1,44% ) | 140 222 $ | 31/03/2024 |
Postes actifs de Timothy Mitchell
| Sociétés | Poste | Début |
|---|---|---|
| SAREUM HOLDINGS PLC | Founder | 01/08/2003 |
Anciens postes connus de Timothy Mitchell
| Sociétés | Poste | Fin |
|---|---|---|
| Millennium Pharmaceuticals Research & Development Ltd. | Corporate Officer/Principal | - |
Cambridge Discovery Chemistry
 Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAREUM HOLDINGS PLC | Miscellaneous |
| Entreprise privées | 2 |
|---|---|
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Commercial Services |
| Millennium Pharmaceuticals Research & Development Ltd. |
